Long-term Prognosis and Quality of Life in Early Rheumatoid Arthritis Patients Treated by 2015 ACR Guideline (LELAND): a Multicenter Prospective Observational Study in Southern China
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 主要终点
- the proportion of patients achieving treat to target
研究概览
简要总结
To focus on the real world treat-to-target rate of early rheumatoid arthritis patients who will be treated according to the 2015 American College of Rheumatology Guideline for the Treatment of RA.
To explore the factors which influence the treat-to-target outcome.
详细描述
Resent study showed that rapid progression of cartilage and bone damage could happen on the early state of RA patients, so the clinicians should try the best to stop the trend, such as early diagnosis, early treatment and treat-to-target. But only half of the RA patients could reach low disease activity in the whole world and about 10% in China.
The investigators enroll early RA patients who are treated according to the 2015 American College of Rheumatology Guideline. The relevant data are collected and analyzed by the statistician including clinical data, imaging markers, blood samples and patient-reported outcomes every 3 months.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •≥18 years,
- •be diagnosed with RA according to the 1987 or 2010 ACR criteria,
- •in the course of the disease within 6 months,
- •fill out questionnaires by oneself,
- •fully understand the survey, agree to take part in the survey with signing the informed consent, and authority the researchers to expose and use his or her personal health information.
排除标准
- •woman in pregnancy, lactation or plan to pregnant in the next 2 years,
- •before enter this study, the patient joint any other RA clinical study in the past 24 weeks,
- •according to the clinicians, one may not report his /or her life quality or the utilization of leading medical resources.
研究组 & 干预措施
early RA patients
patients must fulfill the 1987 ACR classification criteria for rheumatoid arthritis or 2010 Rheumatoid arthritis classification criteria of ACR/EULAR, and meet the condition that the course of disease was no more than 6 months. If enrolled, patients will be treated with disease modified antirheumatic drugs or biological agents.
干预措施: disease modified antirheumatic drugs or biological agents (Drug)
结局指标
主要结局
the proportion of patients achieving treat to target
时间窗: 2018-4-25 to 2022-7-1
calculate the proportion of patients achieving treat to target according to the change of DAS28 score
次要结局
- the change of The Work Productivity and Activity Impairment Questionnaire(WPAI)(2018-4-25 to 2022-7-1)
- the change of European Quality of Life-5 Dimensions(EQ-5D)(2018-4-25 to 2022-7-1)
- the change of Short Form 36 Health Survey Questionnaire(SF-36)(2018-4-25 to 2022-7-1)
- the change of Health Assessment Questionnaire Disability Index(HAQ-DI)(2018-4-25 to 2022-7-1)
研究者
Min Yang
Director, Head of Rheumatology, Principal Investigator, Clinical Professor
Nanfang Hospital, Southern Medical University